Stay updated on VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial page.

Latest updates to the VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added; a government-funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA general funding/operational notice was added and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedUI/metadata updates: 'Show glossary' added; capitalization changes for QC-related labels (Met QC Criteria, Data); and the release notes show Revision: v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a dedicated Locations section listing trial sites by state (Arizona, California, Florida, Kentucky, Michigan, Minnesota, Ohio, Pennsylvania, Texas, West Virginia). Removed the separate state location pages.SummaryDifference0.9%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no study data, eligibility criteria, locations, or outcomes appear to have changed.SummaryDifference0.0%

Stay in the know with updates to VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial page.